An interventional study of Patient education modules providing information on the psychological aspects of atopic dermatitis treatment and management. in Atopic Dermatitis (AD), sponsored by University of Alberta. Completed at 3 sites in Canada. Open to participants aged 4 Years and older. Per ClinicalTrials.gov, last updated 2026-09-23.
Sponsored by University of Alberta · Not applicable, Interventional, and Supportive care
In a previous part of this study, we created educational modules about the psychodermatology of inflammatory skin conditions, with a particular emphasis on atopic dermatitis, for patients. These modules will empower patients to better manage both the psychological and physical aspects of their skin conditions. As part of this project, we aim to conduct a clinical trial to determine the effectiveness of these modules on eczema severity and health-related quality of life in patients. We hope to use these findings to develop and disseminate accessible educational material on the psychological aspects of dermatologic care.
1,419 studies on the registry are indexed under Dermatitis, Atopic; 258 are open to participants now.
This study's enrollment of 57 is below the median of 83 across 1,125 interventional studies indexed under Dermatitis, Atopic.
Browse Dermatitis, Atopic studies →University of Alberta is the lead sponsor of 800 studies on the registry; 168 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
This arm consists of participants living with atopic dermatitis that will be trialing our educational modules. In addition to receiving standard medical care, they will be asked to complete these modules throughout the duration of the study period.
Behavioral: Patient education modules providing information on the psychological aspects of atopic dermatitis treatment and management.
This arm will consist of participants living with atopic dermatitis. They will receive standard medical care, but will not be given access to the educational modules until the study period has been completed.
Provision of online patient educational modules (in addition to patients receiving regular clinical action/ appointments at the Kaye Edmonton Clinic, the Stollery Children's Hospital, and the Rao Dermatology Clinic for Atopic Dermatitis).
Health-Related Quality of Life
Quality of Life will be measured using the Dermatology Life Quality Index (DLQI). The scores range from 0 to 30 (higher score indicative of worse outcomes)
Time frame: Baseline, 4 weeks, and 12 weeks
Eczema Disease Severity
Eczema Disease Severity will be measures using the Patient-Oriented SCORing for Atopic Dermatitis (PO-SCORAD). Scores range between 0 and 103 points (higher score indicative of worse outcomes)
Time frame: Baseline, 4 weeks, and 12 weeks
Plan to share: No — Not necessary
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Alberta